(Q67490095)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1318870%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

title

Phase II trial of caracemide (NSC 253272) in advanced unresectable non-small cell bronchogenic carcinoma. An Illinois Cancer Council study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1318870%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

main subject

phase II clinical trial

1 reference

T. Lad

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1318870

12 September 2022

J. Schor

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1318870

12 September 2022

M. Mullane

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1318870

12 September 2022

R. Carroll

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1318870

12 September 2022

D. Chernicoff

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1318870

12 September 2022

R. Blough

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1318870

12 September 2022

L. Weidner

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1318870

12 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1318870

12 September 2022

publication date

1 April 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1318870%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

14 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1318870%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1318870%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1318870%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

page(s)

27-28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1318870%20AND%20SRC:MED&resulttype=core&format=json

Phase II study of caracemide in advanced or recurrent non-small cell lung cancer

14 September 2019

cites work

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/1318870

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Phase I trial of caracemide using bolus and infusion schedules

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/1318870

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Inhibition of ribonucleotide reductase by caracemide

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/1318870